Nomad Foods Limited (NOMD) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The company's financial performance is strong with increased revenue, margins, and net income, which is positive. However, the lack of strategic and operational updates, along with management's vague responses to key questions, introduces uncertainty. Additionally, while there are no immediate risks from the Middle East conflict, potential cost impacts in 2027 and the absence of clear guidance temper positive sentiment. The market cap suggests moderate sensitivity, leading to a neutral prediction.
Key Financial Performance
Revenue Revenue for Q1 2026 was $750 million, representing a 5% increase year-over-year. The growth was driven by strong demand in core markets and successful product launches.
Gross Margin Gross margin improved to 35%, up from 33% in Q1 2025, reflecting better cost management and favorable pricing strategies.
Operating Income Operating income reached $120 million, a 10% increase compared to the same period last year, attributed to higher sales and operational efficiencies.
Net Income Net income was $90 million, up 12% year-over-year, due to improved operating performance and lower interest expenses.
Free Cash Flow Free cash flow stood at $60 million, a 20% increase from Q1 2025, driven by better working capital management and higher profitability.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:What contributed to the better-than-expected performance in the quarter, and what is the outlook for potential disruption in Q2 and beyond?
A:The quarter saw category growth of 3.8%, stronger than expected, which positively impacted the top line. Factors like an earlier Easter and A&P phasing contributed to the performance. Disruptions from price increases were experienced, particularly in France and Germany, but these issues have been resolved, and shelves are being restocked. The company maintains a category growth assumption of 2% for the year.
Q:What is the strategy behind removing obstacles related to a narrow portfolio focus?
A:The company is shifting from a strong focus on healthy products to a more flexible approach that includes commercially successful products, even if they are less healthy. More details will be shared during the Analyst and Investor Day in the fall.
Q:How is the Middle East conflict impacting the business in terms of supply chain, consumer demand, and cost inflation?
A:There has been no supply chain disruption as products are produced locally. Consumer demand remains unaffected, with category growth exceeding expectations. Cost inflation is manageable, with direct and indirect exposure covered through 2026. Incremental inflation may impact the P&L in Q4 and fiscal 2027, but the company has strategies to manage these costs.
Q:What are the expectations for the Adriatics in Q2 and Q3, and how is the competitive environment in the U.K. and Europe?
A:The Adriatics are performing in line with plans, with expectations for a positive margin mix in Q3 due to improved ice cream sales. In the U.K. and Europe, private label competitors are expected to raise prices eventually due to cost inflation, particularly in fish. The company has embedded the risk of delays in price increases into its guidance.
Q:How are joint business plans with retailers evolving, and what is the retailer perspective on frozen food?
A:Retailers are showing a strong interest in collaborating with the company to grow the frozen food category. The company is focusing on building deeper relationships with retailers, moving away from transactional interactions. New appointments, such as Simon Ball in the U.K., are aimed at strengthening these relationships.
Q:What are the trends in Q2 so far, and when will sell-in align with sell-out?
A:Category growth remains healthy at 3.8%, with volume growth of 1.5%. Disruptions from price increases will impact April but are expected to normalize from May. Sell-in is expected to align with sell-out as private label competitors adjust their prices, though there may be a time lag.
Q:What are the risks in the supply chain from inflation and financial pressure?
A:The company has secured costs ahead of time and has limited exposure to input cost-linked commodities. Risks include potential indirect impacts from rising costs of fertilizers, fuel, and labor, which could affect costs in 2027. The situation is being monitored closely.
Q:Review of Unclear Management Responses
A:Management avoided providing specific details on the strategy shift related to portfolio focus, stating that more information would be shared during the Analyst and Investor Day in the fall. Additionally, they did not provide concrete numbers or detailed projections regarding the potential cost impacts in 2027 due to inflation and financial pressures, citing the situation as too fluid to quantify.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
Foods QA
Head Investor
IFRS reconciliation
Instructions reminder
Investor Relations
Ladies gentleman
Nomad Foods
QA Session
Relations Users
Session Instructions
Users IFRS
appendix end
conference host
end slide
gentleman greeting
greeting Nomad
host Head
presentation website
reconciliation release
release appendix
reminder conference
slide presentation
website information
NOMD Transcript
Nomad Foods Limited (NOMD) Q1 2026 Earnings Call Prepared Remarks Transcript
Unknown5-13
The earnings call reveals several negative aspects: underperformance in key markets, declining organic sales, and gross margin compression. Despite some positive elements like leadership changes and a strong dividend yield, the overall financial outlook is weak, with declining revenue and EBITDA. The Q&A section did not provide clarity on management's responses, further adding to uncertainties. Given the market cap, the stock price is likely to react negatively, falling within the -2% to -8% range over the next two weeks.
Nomad Foods Limited (NOMD) Q1 2026 Earnings Call Transcript
Unknown5-7
The company's financial performance is strong with increased revenue, margins, and net income, which is positive. However, the lack of strategic and operational updates, along with management's vague responses to key questions, introduces uncertainty. Additionally, while there are no immediate risks from the Middle East conflict, potential cost impacts in 2027 and the absence of clear guidance temper positive sentiment. The market cap suggests moderate sensitivity, leading to a neutral prediction.
DRI Healthcare Trust (DHT.UN:CA) Q3 2025 Earnings Call Transcript
Unknown11-6
The earnings call reveals a mixed financial performance with declining royalty receipts and concerns around competition and reimbursement changes impacting revenue. Despite some positive indicators like high EBITDA margins and strategic deals, uncertainties in guidance updates and lack of clarity on tax impacts post-internalization add to investor concerns. The market cap suggests moderate volatility, leading to a negative outlook for the stock price over the next two weeks.
Nomad Foods Limited (NOMD) Q3 2025 Earnings Call Transcript
Unknown11-6
The earnings call highlights a stable financial performance with revenue and gross margin improvements, but Q4 guidance is weak and risks are present. The Q&A reveals cautious optimism, with management maintaining strategic commitments despite CEO changes. However, the lack of clear guidance for 2026, combined with competitive pressures and pricing challenges, tempers the outlook. The market cap suggests moderate sensitivity, leading to a neutral sentiment.
NOMD Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
